Interpretation of lung tumours in the WHO classification of thoracic tumours (5th edition)

doi:10.19401/j.cnki.1007-3639.2021.07.003

China Oncology ›› 2021, Vol. 31 ›› Issue (7): 574-580.doi: 10.19401/j.cnki.1007-3639.2021.07.003

• Specialists’ Commentary • Previous Articles Next Articles

Interpretation of lung tumours in the WHO classification of thoracic tumours (5th edition)

LI Yuan¹ , XIE Huikang² , WU Chunyan ²

1. Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; 2. Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China

Online:2021-07-30 Published:2021-08-03
Contact: WU Chunyan E-mail: wuchunyan581@163.com

Abstract

Abstract: The International Agency for Research on Cancer (IARC) published the WHO classification of thoracic tumours (5th edition) in May 2021. Compared with the 4th edition published in 2015, the 5th edition changed the framework of the main chapters, added/adjusted the nomenclature and classification of some tumours, and enriched the epidemiology, etiology, histopathology, molecular genetics and other related content. This article briefly introduced the major changes in the classification of lung tumours in the WHO classification of thoracic tumours (5th edition).

Key words: WHO, Lung tumour, Classification

LI Yuan , XIE Huikang , WU Chunyan . Interpretation of lung tumours in the WHO classification of thoracic tumours (5th edition)[J]. China Oncology, 2021, 31(7): 574-580.

[1]	WU Chunyan , XIE Huikang , LI Yuan . Interpretation of pleura, pericardium and thymus tumours updates in the WHO classification of thoracic tumours (5th edition) [J]. China Oncology, 2021, 31(9): 769-774.
[2]	YANG Xin, ZHANG Zhen. Research progress of artificial intelligence based on deep learning in digital pathology [J]. China Oncology, 2021, 31(2): 151-155.
[3]	The Society of Gynecological Cancer of China Anti-Cancer Association, Chinese Society of Pathology of the Chinese Medical Association, National Pathology Quality Control Center. The Chinese Expert Consensus Recommendations on Molecular Testing in Endometrial Cancer (2021 edition) [J]. China Oncology, 2021, 31(11): 1126-1144.
[4]	REN Caiyue, WANG Shengping, ZHANG Shengjian, PENG Weijun. The value of MSCT signs combined with texture analysis in preoperatively predicting WHO simplified pathological classification of thymic epithelial tumors [J]. China Oncology, 2020, 30(6): 468-474.
[5]	SUN Xiangjie, YANG Wentao. Issues on immunohistochemistry for molecular classification of breast cancer [J]. China Oncology, 2019, 29(3): 161-165.
[6]	LI Xiaoqiu. Updates on the WHO classification of the mucosal lymphomas of the head and neck [J]. China Oncology, 2019, 29(11): 841-844.
[7]	LUO Jurui, CHEN Xingxing, YANG Zhaozhi, et al. A phase Ⅱ study of hypofractionated whole breast irradiation in patients with early stage breast cancer after breast-conserving surgery: safety and efficacy analysis [J]. China Oncology, 2018, 28(10): 769-775.
[8]	HUANG Shuang, JIANG Feng, CHEN Yuanyuan, et al. Validation of T classifications in the 7th edition UICC staging system and recommendation of a simplified T classifications based on intensity-modulated radiotherapy [J]. China Oncology, 2016, 26(12): 1012-1017.
[9]	SHEN Xigang, ZHOU Liangping, PENG Weijun, et al. Clinical application study on malignant metastatic diseases between DWIBS and PET/CT [J]. China Oncology, 2015, 25(6): 457-467.
[10]	HU Naijun, CAI Gang, XU Qing, et al. Comparison of setup variations between two fixation devices for radiation after breast-conserving surgery [J]. China Oncology, 2015, 25(11): 911-916.
[11]	ZHU Hong, LV Bo, LI Yun-hai, WANG Hong-lin, ZHAO Sen. Analysis of prognostic factors and index model in patients with brain metastases after wholebrain radiotherapy [J]. China Oncology, 2014, 24(6): 457-462.
[12]	SHEN Xi-gang, ZHOU Liang-ping, PENG Wei-jun, MAO Jian, ZHANG Ling, YAO Zhifeng,CHENG Jing-yi, LIU Xiao-hang, DING Jian-hui, YUE Lei. A control study between DWIBS and bone scintigraphy mapping in the diagnosis of bone metastatic diseases [J]. China Oncology, 2014, 24(3): 187-196.
[13]	CHANG Kun, YANG Xiao-qun, WANG Chao-fu, GAN Hua-lei, ZHENG Ai-hua, YANG Jun, DAI Bo, QU Yuan-yuan, ZHANG Hai-liang, SHI Guo-hai, ZHU Yao, YE Ding-wei. Comparative analysis of whole mount processing and conventional sampling of radical prostatectomy specimens [J]. China Oncology, 2014, 24(11): 824-829.
[14]	LI Xiao-qiu. New advances in lymphoma pathology [J]. China Oncology, 2014, 24(10): 721-726.

Interpretation of lung tumours in the WHO classification of thoracic tumours (5th edition)

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 14

Recommended Articles

Metrics

Comments